Search Results

There are 2685 results for: content related to: Dasatinib combined with docetaxel for castration-resistant prostate cancer

  1. Phase I Study of the Effect of Gastric Acid pH Modulators on the Bioavailability of Oral Dasatinib in Healthy Subjects

    The Journal of Clinical Pharmacology

    Volume 49, Issue 6, June 2009, Pages: 700–709, Dr Timothy Eley, Dr Feng R. Luo, Dr Shruti Agrawal, Dr Ashish Sanil, Dr James Manning, Dr Tong Li, Dr Anne Blackwood-Chirchir and Dr Richard Bertz

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270009333854

  2. You have free access to this content
    Design, Synthesis, and Evaluation of Dasatinib–Amino Acid and Dasatinib–Fatty Acid Conjugates as Protein Tyrosine Kinase Inhibitors


    Volume 12, Issue 1, January 5, 2017, Pages: 86–99, Prof. Rakesh K. Tiwari, Dr. Alex Brown, Dr. Neda Sadeghiani, Dr. Amir Nasrolahi Shirazi, Jared Bolton, Amanda Tse, Prof. Gennady Verkhivker, Prof. Keykavous Parang and Prof. Gongqin Sun

    Version of Record online : 5 DEC 2016, DOI: 10.1002/cmdc.201600387

  3. You have free access to this content
    Phase 1 pharmacokinetic and drug-interaction study of dasatinib in patients with advanced solid tumors


    Volume 116, Issue 6, 15 March 2010, Pages: 1582–1591, Faye M. Johnson, Shruti Agrawal, Howard Burris, Lee Rosen, Navneet Dhillon, David Hong, Anne Blackwood-Chirchir, Feng R. Luo, Oumar Sy, Sanjeev Kaul and Alberto A. Chiappori

    Version of Record online : 27 JAN 2010, DOI: 10.1002/cncr.24927

  4. You have free access to this content
    The impact of dasatinib on pregnancy outcomes

    American Journal of Hematology

    Volume 90, Issue 12, December 2015, Pages: 1111–1115, Jorge E. Cortes, Elisabetta Abruzzese, Ekaterina Chelysheva, Mausumee Guha, Nicola Wallis and Jane F. Apperley

    Version of Record online : 12 OCT 2015, DOI: 10.1002/ajh.24186

  5. Targeting Fyn in Ras-transformed cells induces F-actin to promote adherens junction-mediated cell–cell adhesion

    Molecular Carcinogenesis

    Volume 54, Issue 10, October 2015, Pages: 1181–1193, Sarah E. Fenton, Kelli A. Hutchens and Mitchell F. Denning

    Version of Record online : 29 JUN 2014, DOI: 10.1002/mc.22190

  6. You have free access to this content
    Dasatinib induces autophagic cell death in human ovarian cancer


    Volume 116, Issue 21, 1 November 2010, Pages: 4980–4990, Xiao-Feng Le, Weiqun Mao, Zhen Lu, Bing Z. Carter and Robert C. Bast Jr

    Version of Record online : 13 JUL 2010, DOI: 10.1002/cncr.25426

  7. You have free access to this content
    Dasatinib treatment for Philadelphia chromosome-positive leukemias


    Volume 115, Issue 7, 1 April 2009, Pages: 1381–1394, Hanna Jean Khoury, François Guilhot, Timothy P. Hughes, Dong-Wook Kim and Jorge E. Cortes

    Version of Record online : 4 FEB 2009, DOI: 10.1002/cncr.24155

  8. Dasatinib inhibits mammary tumour development in a genetically engineered mouse model

    The Journal of Pathology

    Volume 230, Issue 4, August 2013, Pages: 430–440, Saadia A Karim, Helen Creedon, Hitesh Patel, Neil O Carragher, Jennifer P Morton, William J Muller, Thomas RJ Evans, Barry Gusterson, Owen J Sansom and Valerie G Brunton

    Version of Record online : 9 JUL 2013, DOI: 10.1002/path.4202

  9. You have free access to this content
    Enhancement of natural killer cell effector functions against selected lymphoma and leukemia cell lines by dasatinib

    International Journal of Cancer

    Volume 131, Issue 6, 15 September 2012, Pages: E916–E927, Nicole Hassold, Katharina Seystahl, Kristina Kempf, Doris Urlaub, Michael Zekl, Hermann Einsele, Carsten Watzl, Jörg Wischhusen and Ruth Seggewiss-Bernhardt

    Version of Record online : 4 APR 2012, DOI: 10.1002/ijc.27537

  10. Dasatinib inhibits progenitor cell proliferation from polycythaemia vera

    European Journal of Clinical Investigation

    Volume 38, Issue 8, August 2008, Pages: 578–584, M. Wappl, E. Jaeger, B. Streubel, H. Gisslinger, I. Schwarzinger, P. Valent and L. Oehler

    Version of Record online : 17 JUL 2008, DOI: 10.1111/j.1365-2362.2008.01982.x

  11. You have full text access to this Open Access content
    Through the open door: Preferential binding of dasatinib to the active form of BCR-ABL unveiled by in silico experiments

    Molecular Oncology

    Volume 7, Issue 5, October 2013, Pages: 968–975, Erik Laurini, Paola Posocco, Maurizio Fermeglia, Don L. Gibbons, Alfonso Quintás-Cardama, Sabrina Pricl

    Version of Record online : 15 JUN 2013, DOI: 10.1016/j.molonc.2013.06.001

  12. You have free access to this content
    Dynamics and management of cytopenias associated with dasatinib therapy in patients with chronic myeloid leukemia in chronic phase after imatinib failure


    Volume 115, Issue 17, 1 September 2009, Pages: 3935–3943, Alfonso Quintás-Cardama, Fabio Pires De Souza Santos, Hagop Kantarjian, Susan O'Brien, Stefan Faderl, Ahmed Awais, Gautam Borthakur and Jorge Cortes

    Version of Record online : 10 JUN 2009, DOI: 10.1002/cncr.24432

  13. You have free access to this content
    Dasatinib inhibits B cell receptor signalling in chronic lymphocytic leukaemia but novel combination approaches are required to overcome additional pro-survival microenvironmental signals

    British Journal of Haematology

    Volume 153, Issue 2, April 2011, Pages: 199–211, Alison M. MCCaig, Emilio Cosimo, Michael T. Leach and Alison M. Michie

    Version of Record online : 24 FEB 2011, DOI: 10.1111/j.1365-2141.2010.08507.x

  14. You have full text access to this OnlineOpen article
    Direct effect of dasatinib on signal transduction pathways associated with a rapid mobilization of cytotoxic lymphocytes

    Cancer Medicine

    Volume 5, Issue 11, November 2016, Pages: 3223–3234, Noriyoshi Iriyama, Yoshihiro Hatta and Masami Takei

    Version of Record online : 10 OCT 2016, DOI: 10.1002/cam4.925

  15. Direct effect of dasatinib on proliferation and cytotoxicity of natural killer cells in in vitro study

    Hematological Oncology

    Volume 31, Issue 3, September 2013, Pages: 156–163, Takayoshi Uchiyama, Naoya Sato, Miwako Narita, Akie Yamahira, Minami Iwabuchi, Tatsuo Furukawa, Hirohito Sone and Masuhiro Takahashi

    Version of Record online : 29 OCT 2012, DOI: 10.1002/hon.2034

  16. You have free access to this content
    The tyrosine kinase inhibitor dasatinib suppresses cytokine production by plasmacytoid dendritic cells by targeting endosomal transport of CpG DNA

    European Journal of Immunology

    Volume 43, Issue 1, January 2013, Pages: 93–103, Haruyuki Fujita, Toshio Kitawaki, Takayuki Sato, Takahiro Maeda, Shimeru Kamihira, Akifumi Takaori-Kondo and Norimitsu Kadowaki

    Version of Record online : 6 DEC 2012, DOI: 10.1002/eji.201242699

  17. You have free access to this content
    Ingredients in Fruit Juices Interact with Dasatinib Through Inhibition of BCRP: A New Mechanism of Beverage–Drug Interaction

    Journal of Pharmaceutical Sciences

    Volume 104, Issue 1, January 2015, Pages: 266–275, Brett Fleisher, Jesse Unum, Jie Shao and Guohua An

    Version of Record online : 21 NOV 2014, DOI: 10.1002/jps.24289

  18. You have free access to this content
    Dasatinib inhibits the proliferation and function of CD4+CD25+ regulatory T cells

    British Journal of Haematology

    Volume 144, Issue 2, January 2009, Pages: 195–205, Fei Fei, Yingzhe Yu, Anita Schmitt, Markus Thomas Rojewski, Baoan Chen, Marlies Götz, Hartmut Döhner, Donald Bunjes and Michael Schmitt

    Version of Record online : 11 NOV 2008, DOI: 10.1111/j.1365-2141.2008.07433.x

  19. You have free access to this content
    Dasatinib sensitizes primary chronic lymphocytic leukaemia lymphocytes to chlorambucil and fludarabine in vitro

    British Journal of Haematology

    Volume 143, Issue 5, December 2008, Pages: 698–706, Lilian Amrein, Tiffany A. Hernandez, Cristiano Ferrario, James Johnston, Spencer B. Gibson, Lawrence Panasci and Raquel Aloyz

    Version of Record online : 21 OCT 2008, DOI: 10.1111/j.1365-2141.2008.07418.x

  20. You have full text access to this OnlineOpen article
    Dasatinib induces fast and deep responses in newly diagnosed chronic myeloid leukaemia patients in chronic phase: clinical results from a randomised phase-2 study (NordCML006)

    European Journal of Haematology

    Volume 94, Issue 3, March 2015, Pages: 243–250, Henrik Hjorth-Hansen, Leif Stenke, Stina Söderlund, Arta Dreimane, Hans Ehrencrona, Tobias Gedde-Dahl, Bjørn Tore Gjertsen, Martin Höglund, Perttu Koskenvesa, Kourosh Lotfi, Waleed Majeed, Berit Markevärn, Lotta Ohm, Ulla Olsson-Strömberg, Kari Remes, Merja Suominen, Bengt Simonsson, Kimmo Porkka, Satu Mustjoki, Johan Richter and for the Nordic CML Study Group (NCMLSG)

    Version of Record online : 13 SEP 2014, DOI: 10.1111/ejh.12423